RTTNews | Aug 18, 2020 09:27AM EDT

09:27 Tuesday, August 18, 2020 (RTTNews.com) - Premier Inc. (PINC) said, as part of the partnership with AstraZeneca, Premier Applied Sciences has implemented evidence-based care practices with nearly 370 hospitals across the U.S. designed to prevent patients with hyperkalemia from requiring treatment in the acute-care setting. Premier Applied Sciences and AstraZeneca have developed a protocol for monitoring and treating patients with hyperkalemia. Hospitals participating in the partnership are eligible for discounts on LOKELMA, a potassium binder indicated for the treatment of hyperkalemia in adults, from AstraZeneca.

Denise Juliano, Group Vice President for Premier Applied Sciences, said: "We have been able to identify gaps in care and create a discharge protocol to help patients better manage their hyperkalemia status and help reduce readmissions to the hospitals."

Read the original article on RTTNews ( https://www.rttnews.com/3122206/premier-announces-hyperkalemia-discharge-protocol-to-reduce-readmissions-to-hospitals.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved